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Abstract
Vibrio vulnificus is a pathogen that causes both severe necrotizing wound infections and life-threatening food-borne
infections. Food-borne infection is particularly lethal as the infection can progress rapidly to primary septicemia resulting in
death from septic shock and multiorgan failure. In this study, we use both bioluminescence whole animal imaging and V.
vulnificus bacterial colonization of orally infected mice to demonstrate that the secreted multifunctional-autoprocessing RTX
toxin (MARTXVv) and the cytolysin/hemolysin VvhA of clinical isolate CMCP6 have an important function in the gut to
promote early in vivo growth and dissemination of this pathogen from the small intestine to other organs. Using
histopathology, we find that both cytotoxins can cause villi disruption, epithelial necrosis, and inflammation in the mouse
small intestine. A double mutant deleted of genes for both cytotoxins was essentially avirulent, did not cause intestinal
epithelial tissue damage, and was cleared from infected mice by 36 hours by an effective immune response. Therefore,
MARTXVv and VvhA seem to play an additive role for pathogenesis of CMCP6 causing intestinal tissue damage and
inflammation that then promotes dissemination of the infecting bacteria to the bloodstream and other organs. In the
absence of these two secreted factors, we propose that this bacterium is unable to cause intestinal infection in humans.
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Introduction
Vibrio vulnificus is a motile, Gram-negative, opportunistic human
pathogen capable of causing severe to life-threatening infection in
individuals with predisposing conditions, including liver damage,
hereditary hemochromatosis and compromised immune systems
[1–3]. Infection can result from consumption of contaminated
seafood or from exposing an open wound to water harboring the
pathogen. Wound infection can progress to edema, cellulitis,
ecchymoses and necrotizing fasciitis at the site of infection [4,5].
The mortality of wound infection is about 25% because primary
septicemia does not frequently occur [5,6]. By contrast, V. vulnificus
food-borne infection rapidly progresses to primary septicemia with
symptoms that include high fever, chills, decreased blood pressure
and septic shock [5,7–9]. These infections result in a much higher
mortality rate ($50%) with rates as high as 100% in the absence of
antibiotic therapy [5,6,10]. Hence, a critical aspect of V. vulnificus
pathogenesis is its ability to infect a host via the gastrointestinal
tract and then rapidly spread from the small intestine to the blood
stream.
Although several secreted virulence factors of V. vulnificus have
been identified [3,11], only two have been previously associated
with increased death during intestinal infection: the secreted
cytolytic/hemolysin pore-forming toxin encoded by vvhA [12] and
the multifunctional autoprocessing RTX (MARTXVv) toxin
encoded by gene rtxA1 [13–15]. In vitro, both of these toxins are
cytolysins associated with lysis of a variety of cell types including
erythrocytes, epithelial cells and macrophages, albeit by different
molecular mechanisms [12,16–22].
The role of these toxins in vivo during infection has been less
well-characterized. When injected directly to the bloodstream,
purified VvhA is lethal at sub-mg levels and causes hypotension
and tachycardia, along with skin and pulmonary damage [12,23].
However, deletion of vvhA from V. vulnificus had either a slight or
no defect in virulence when delivered intraperitoneally (i.p.) and
no defect when delivered intradermally (i.d.) [23]. When delivered
intragastically (i.g.) to neutropenic mice, loss of vvhA resulted in a
detectable, albeit modest, 4–5 fold increase in median lethal dose
(LD50) [12,23].
In comparison to VvhA, MARTXVv has been shown to have a
significantly greater contribution to mouse lethality. A mutant in
rtxA1 has a 100- to 500-fold increase in LD50 compared to wild-
type when inoculated i.p. [14,17,18] and a 13-fold increase when
inoculated subcutaneously (s.c.) [19]. A deletion of rtxA1 caused a
180 to 2600-fold increase in LD50 in an i.g. infection model with
the contribution of the gene deletion to virulence varying
depending on the specific toxin variant that is expressed [15].
Comparison across different studies suggest that the MARTXVv
toxin is the most significant virulence factor of V. vulnificus and both
MARTXVv and VvhA exert a greater effect on i.g. and septicemic
infection compared to i.p., s.c. or i.d. infection.
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MARTXVv and VvhA contribute to food-borne infection by
highly virulent V. vulnificus strains that produce a particularly
potent variant of the MARTXVv toxin [15]. We used biolumi-
nescence imaging (BLI) and measurement of bacterial colonization
to monitor early events in growth and dissemination of V. vulnificus
strain CMCP6 in mice after i.g. infection. This study shows that
both MARTXVv and VvhA from CMCP6 contribute to the onset
of colonization and to significant bacterial growth sooner after
inoculation. These data are consistent with a role of both toxins in
disabling innate immune cells in the small intestine allowing for
more rapid growth. However, the effect of the toxins is not limited
to innate cells as these toxins are also here shown to directly cause
epithelial tissue damage. The combination of rapid growth and
tissue damage is essential for the dissemination to the bloodstream
earlier during the infection cycle and this rapid dissemination is
the leading factor promoting death.
Results
Characterization of luciferase-expressing V. vulnificus
V. vulnificus CMCP6 can cause lethal infection of adult mice
inoculated i.g. [15]. To more directly measure how disease
progresses during early infection, we transformed V. vulnificus
CMCP6 with plasmid pHGJ1 that expresses the Photorhabdus
luminescens lux genes from the constitutively active Vibrio cholerae
ompC promoter (see material and methods). The LD50 for the
resulting strain CMCP6lux (HG0905) was 3.1610
5 CFU (Table
S1), about 13-fold higher than the LD50 of 2.4610
4 CFU
previously determined for the parent strain CMCP6 in this mouse
infection model [15]. The presence of the plasmid also caused an
in vitro defect in growth in antibiotic-free culture media (Figure S1).
The difference in both in vitro growth and in vivo virulence between
the parent strain CMCP6 and CMCP6lux (HG0905) is likely due
to spontaneous bacterial death upon plasmid loss. To maintain the
lux reporter without antibiotic selection, the lux plasmid (pHGJ1)
carries the hok/sok plasmid addiction system [24]. Bacteria that lose
the plasmid during cell division will die upon dilution of the less
stable antitoxin. The advantage of this system is that only bacteria
that produce luciferase survive and thus there is no contribution to
infection from bacteria that are not lux
+. In addition, the
expression of the luciferase genes also probably contribute to the
reduced virulence of HG0905 compared to CMCP6 since a
CMCP6 that carries a plasmid deleted of the lux genes (HG0909)
was slightly more virulent than HG0905 (Figure S1).
In this paper, we compared lux+ strains derived from parent strain
CMCP6and we confirmed that there was no invitrogrowth difference
in mutant strains CMCP6luxDrtxA1 (HG0906), CMCP6luxDvvhBA
(HG0907)andCMCP6luxDrtxA1vvhBA(HG0908)containingplasmid
pHGJ1 in antibiotic-free culture media (Figure 1G) compared to the
isogenic parent CMCPlux (HG0905). Further, we confirmed by
lactate dehydrogenase (LDH) releaseassays that the mutants carrying
pHGJ1 have defects in HeLa cell lysis consistent with previous
findings [14,18]. Specifically, the DrtxA1 mutation reduced rapid
HeLa cell lysis while the DvvhBA mutation eliminated slow cell lysis.
T h ed o u b l em u t a n td i dn o tl y s ec e l l s( F i g u r eS 2 ) .
The effect on virulence of the lux+ plasmids was less evident in
the mutant strains since these strains likely are not growing in vivo
and thus less likely to lose the plasmid during rapid replication.
Thus, the LD50 for CMCP6luxDrtxA1 (HG0906) matched our
previously determined LD50 of 8.0610
7 CFU for plasmid-free
CMCP6DrtxA1 and thus the deletion of rtxA1 exhibited only a 260-
fold effect on virulence due to the reduced virulence of the isogenic
wild type. Deletion of vvhA caused a 61-fold decrease in virulence
with an LD50 of 1.9610
7. This result was surprising since previous
studies of i.g. infection with a DvvhA mutant in isolate YJ016
revealed only a modest 5-fold virulence defect [12]. However, the
previous study was conducted in highly susceptible iron-overload-
ed, neutropenic mice, which may have masked the importance of
this factor for intestinal infection. Consistent with a role of both
factors in infection by CMCP6, the CMCP6luxDrtxA1DvvhBA
double mutant (HG0908) was essentially avirulent with an
LD50.10
9 (Table S1).
In vivo expansion of V. vulnificus after i.g. infection
To monitor how rapidly V. vulnificus bacteria expand in vivo,
bioluminescence from mice infected with CMCP6lux (HG0905)
was observed and quantified at defined intervals using an IVIS 100
bioluminescence imager (Xenogen Corp.). As previously described
by others [25], use of anesthesia during orogastric inoculation can
result in accidental lung infection due to contamination of the
larynx during infection. In pilot studies, we similarly found that
some mice developed lung infection. These mice usually died
rapidly, often by 6 hours after infection. In our study, 3 mice
infected with HG0905 developed infection of the lung detectable
by IVIS imaging by 4 hr. These mice were euthanized and
removed from analysis. All other mice did not show detectable
lung infection by IVIS imaging.
At a dose of 1610
6 CFU, 100% of mice with an intestinal
infection died between 12 and 22.5 hr post-inoculation (Figure 1B).
Prior to death, all of the CMCP6lux (HG0905) inoculated mice (6/
6) showed detectable levels of photon flux. Two of the mice
reached our preset detection limit by 4 hr, 3 mice by 8 hr, and all
mice had detectable levels by 12 hr (Figure 1A and B). Of note, all
mice showed a steady rise (mean slope between onset and peak (m)
equals 0.174; Figure 1F) in light emission until the animal was
sacrificed for severe morbidity between 12 and 22.5 hr demon-
strating constant replication of the wild-type bacteria. However,
even though all mice reached at least 7.3 RLU (Relative
Luminescence Unit on a logarithmic scale; Luminescence Unit
represents the photons s
21 cm
22 sr
21) before death, attainment of
Author Summary
Vibrio vulnificus causes disease both by infection of
wounds from seawater and by consumption of contam-
inated foods, especially oysters. Wound infection results in
necrotizing fasciitis and edema in extremities with
mortality of ,25% as the incidence of septicemia is low.
Contaminated food consumption by contrast can lead to
highly invasive infections that progress rapidly from an
intestinal infection to primary septicemia. Case-fatality
rates are $50%, with rates as high as 100% in individuals
who receive no antibiotic therapy. The aim of this study is
to elucidate virulence mechanisms of food-borne infection
of the most highly virulent strains of V. vulnificus.W e
developed a novel intragastric infection model for a highly
virulent clinical isolate from Korea in which we can observe
the bacterial load in live mice and applied this to study of
wild type and strains genetically altered to delete genes
for two secreted cytotoxins. Using this model, we show
that both the multifunctional-autoprocessing RTX toxin
(MARTXVv) and the cytolysin VvhA contribute to rapid in
vivo growth of bacteria and that the presence of these
factors directly correlates with mouse mortality. These
exotoxins are then directly linked to intestinal damage and
inflammation.
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PLoS Pathogens | www.plospathogens.org 2 March 2012 | Volume 8 | Issue 3 | e1002581Figure 1. Bioluminescence quantification and lethality measurement in mice infected with V. vulnificus strains containing pHGJ1. (A)
5–6 weeks old C57BL/6 mice were infected with 1610
6 CFU of HG0905 (CMCP6lux) and isogenic mutants HG0906 (DrtxA1), HG0907 (DvvhBA)o r
HG0908 (DrtxA1vvhBA) strains i.g. as indicated. Representative images were acquired at 0, 4, 8, 12, 15, 19, 22.5 and 36 hr post infection, and the color
scale of total flux represents the photons s
21 cm
22 sr
21 for combined images is shown. (B–E) Survival curve and light emission from every individual
mouse infected with HG0905 (B), HG0906 (C), HG0907 (D) and HG0908 (E) were measured. (F) Slopes (m) between onset and peak point from total
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4–22.5 hr after crossing this threshold.
To demonstrate that photon flux is representative of changes in
intestinal colonization, in a separate experiment, 5 mice inoculated
with 10
6 CFU were euthanized at both 8 and 12 hr. In
accordance with flux readout in the previous experiment
(Figure 1A and B), there was variability in recovered CFU from
the small intestine at 8 hr ranging from 10
4–10
8 CFU or 22t o+3
log unit change from the inoculation dose (Figure 2A). By 12 hr,
all mice were colonized above the infection dose representing 2–5
log units growth (Figure 2B). In addition, there was dissemination
of the bacteria to the liver and spleen by 8 hr, indicating
progression to septicemia in all mice during the earliest stages of
infection (Figure 2C and D). Overall, V. vulnificus CMCP6lux
(HG0905) was shown to expand in vivo and this rapid growth
occurred coincident with dissemination to other tissues shortly
after inoculation.
Loss of MARTXVv results in delayed growth and reduced
virulence
To determine if MARTXVv is the factor that promotes the
rapid growth seen in mice after i.g. infection, we monitored the
effect of deletion of the rtxA1 gene from CMCP6lux on disease
progression. The most apparent phenotype of the resulting strain
HG0906 compared to CMCP6lux (HG0905) was a delay in the
time required to the BLI detection limit (Figure 1A). One of 9 mice
was sacrificed due to lung infection and one mouse was not
infected. Among the 7 infected mice, light production was
detectable in only one (14%) by 4 hr and 3/7 (43%) of mice by
8 hr (Figure 1C). Four mice (50%) showed delayed onset with
detectable light emission only after 8–12 hr. After onset, the
average rate of growth in all infected mice was similar to wild-type
(m=171, Figure 1F). However, unlike CMCP6lux (HG0905)
infected mice, 3 of 7 mice ultimately survived to 36 hr despite the
in vivo bacterial load. In addition, several of the mice succumbed
only late in the experiment indicating, as suggested by LD50
studies (Table S1), that more mice might have survived except for
the stress imposed by repeated anaesthetic regimen necessary for
imaging. Thus, the major effect of loss of the MARTXVv toxin was
delayed onset of bacterial growth to detectable levels. Further,
among the mice that attained high bacterial loads, half failed to
progress to death and the mice cleared the infections. As further
evidence for delayed growth, there was a trend toward reduced
colonization of the small intestine by the CMCP6luxDrtxA1 mutant
(HG0906) at 8 hr that reached statistical significance by 12 hr
(Figure 2A and B). In addition, by 8 hr, there was significantly
reduced dissemination of bacteria to the liver and spleen
(Figure 2C and D). Overall, our results suggest that loss of rtxA1
results in an inability to consistently establish an infection that can
progress to other organs shortly after ingestion of bacteria and thus
the infections are delayed and less severe at least 50% of the time.
Cytolysin/hemolysin VvhA also significantly contributes
to growth and dissemination in vivo
To test if VvhA also contributes to infection, we next tested a
CMCP6luxDvvhBA mutant (HG0907). Results were intermediate
between CMCP6lux and the isogenic DrtxA1 mutant with 7 of 9
mice showing increased light emission beginning 4–12 hr after
inoculation rising to values greater than 7.3 RLU. Similar to both
CMCP6lux and the isogenic DrtxA1 mutant, the 7 mice successfully
infected with CMCP6luxDvvhBA mutant showed a similar rate of
increasing light emission with other strains indicating it does grow
in vivo (m=0.142; Figure 1F). 1 of these 7 mice reversed course and
began to clear the infection while the other 6 succumbed to
infection by 22.5 hr. When assessed for colonization, there was a
consistent trend for reduced colonization of CMCP6luxDvvhBA
mutant (HG0907) in the intestine at 8 hr and 12 hr (Figure 2A
and B) and reduced dissemination during early infection to the
liver and spleen but these values did not achieve statistical
significance (Figure 2C and D). Thus, mice infected with the
DvvhBA mutant showed detectable decreases in numerous
parameters of infection including delayed and reduced death but
this cytolysin does not exert the same impact on progression of
CMCP6 infection as MARTXVv.
Despite its minimal effect when the rtxA1 is intact, expression of
VvhBA by CMCP6lux does account for the residual virulence of
the CMCP6luxDrtxA1 mutant. A CMCP6lux double mutant
eliminating both vvhBA and rtxA1 (HG0908) was nonlethal in
mice at 1610
6 CFU (Figure 1E) except for one mouse sacrificed
due to lung infection. Three of the mice were overall defective for
bacterial growth and did not achieve 7.3 RLU at any time point
and 1 was not infected at all. In 2/8 (25%) mice there was long
12 hour delay to detectable light production (Figure 1E). When
bacteria did expand in vivo, the mean slope from onset of detection
to peak (m=0.164) was similar with those of wild type (Figure 1F).
However, in all cases where mice did achieve high bacteria loads,
the emission of light reversed from a peak between 15 and 22.5 hr
post-inoculation and all mice ultimately cleared the infection.
When tested for colonization, CFU recovered from the small
intestine were significantly reduced at both 8 and 12 hr (Figure 2A
and B) and the bacteria did not disseminate to the liver and spleen
by 8 hr (Figure 2C and D). Overall, these data indicate that in V.
vulnificus strain CMCP6, MARTXVv in conjunction with a
secondary additive contribution from VvhA is essential during
the early stages of infection to promote initiation of the infection
and dissemination to the bloodstream.
In vivo growth of double cytolysin mutant HG0908 is
restored by co-infection with CMCP6lux
Lack of bacterial growth during in vivo infection due to loss of
secreted factors can often be restored by co-infection wherein
mutant bacteria benefit from alteration to the host environment by
the co-infecting strain. These data can reveal that mutant bacteria
are not defective in their ability to replicate in vivo per se, but lack
the capacity to modify the host environment to promote their
growth. To test if HG0908 could be restored for in vivo growth by
co-infection, we transferred a plasmid from which the luxCDABE
operon was deleted (pHGJ2) into CMCP6 and the double
cytolysin mutant strains and competed strains 1:1 with the lux
+
double mutant (HG0908). Thereby, if HG0908 is rescued by co-
infection, total flux during co-infection should increase since all
light signal would originate from HG0908 and not the cytolysin
producing co-infecting strain.
When 5610
5 CFU of lux
2 wild-type (HG0909) and
5610
5 CFU of lux
+ double mutant (HG0908) were co-inoculated,
median light production produced by the double mutant was 6.9
RLU at 8 hr post-infection and reached 7.6 RLU after 12 hr
infection. By contrast, mice infected with 5610
5 CFU of lux+
double mutant (HG0908) and 5610
5 CFU lux
2 double mutant
flux of individual mice were measured. (G) In vitro growth curves of strains in LB broth at 30uC with shaking of HG0905, HG0906, HG0907 and HG0908
for OD600.
doi:10.1371/journal.ppat.1002581.g001
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PLoS Pathogens | www.plospathogens.org 4 March 2012 | Volume 8 | Issue 3 | e1002581Figure 2. Dynamics of bacterial colonization and dissemination. C57BL/6 mice (5–6 weeks old) were infected with 1610
6 CFU of HG0905
(CMCP6lux) and isogenic mutants HG0906 (DrtxA1), HG0907 (DvvhBA) and HG0908 (DrtxA1vvhBA). Small intestines after 8 hr (A) and 12 hr (B) post
infection, liver (C) and spleen (D) were collected, homogenized and plated for CFU counting (*, p,0.05; **, p,0.01). Values are reported as a log
colonization index (Col. Ind.), which is defined as the log of the number of recovered CFU divided by the number of input CFU. Solid line at 0
indicates that CFU recovered was identical to the input CFU (I) while values above the line signify growth and values below the line indicate
clearance. Values below the dashed line (d.l.) were below the detection limit. (E) Co-infections experiments were performed by inoculation of a mouse
with the bacterial suspension prepared by mixing equal numbers of the HG0908 (lux+ DrtxA1vvhBA) and HG0909 (lux
2 CMCP6), and also HG0908 and
HG0910 (lux
2 DrtxA1vvhBA). BLI from mice were acquired after 8 hr and 12 hr. (F) Median values of total flux were also quantified.
doi:10.1371/journal.ppat.1002581.g002
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12 hr (Figure 2E and F).
Thus, the in vivo growth defect of the double cytolysin mutant
HG0908 can be restored by co-infection with a cytolysin
producing strain indicating that HG0908 is not defective in its
ability to replicate in vivo but in its ability to modify the host
environment.
Histopathological evaluation of ileum tissue reveals
MARTXVv and VvhA cause epithelial cell damage
We have demonstrated that MARTXVv and VvhA of V.
vulnificus CMCP6 are required for earlier onset of in vivo growth
after i.g. inoculation. This result is consistent with a recent study
conducted by s.c. infection to model wound-induced infection
using strain YJ016. The s.c. study of YJ016 suggested the
requirement for MARTXVv during infection is primarily for
protection from phagocytes to promote growth [19]. This
conclusion seems to conflict with evidence that cytotoxins of
CMCP6, YJ016, and other V. vulnificus strains are linked to lysis of
both epithelial cells and macrophages in vitro [14,16–19,21]. To
reveal whether the cytotoxins have an additional role beyond
promoting rapid growth during intestinal infection, mice were
inoculated with a lethal dose of CMCP6lux (HG0905) and the
terminal ileal tissue was collected after 8 hr infection for various
histopathological staining. Severe disruption of the intestinal
barrier occurred in the ileum infected with HG0905 (Figure 3A–
C) with many broken villi and barrier disruptions, consistent with
pathology reported in earlier studies in neutropenic mice using
strain YJ016 [12]. Excessive amounts of epithelial cell debris and
heavy cellular infiltration of lamina propria were observed in the
lumen and mucosa of the ileum from mice infected with the wild
type (Figure 3A–C). Staining with anti-CD45 showed extensive
influx of monocytes and other immune cells to the tissue and the
lumen (Figure 3D). Within the destroyed tissue, F4/80 positive
macrophages are present and proinflammatory cytokine IL-1b is
secreted and found distributed in the ruptured tissue (Figure 4A).
The lumen is filled with epithelial debris (stained positive with b-
catenin), lysed macrophages, and IL-1b presumably release from
necrotic macrophages (Figure 3C and 4A).
By contrast, mice infected with 1610
6 CFU of either the
CMCP6luxDrtxA1 mutant (HG0906) or the CMCP6luxDvvhBA
mutant (HG0907) showed no destruction of the villi architecture
and infiltration of the lamina propria except only slight swelling
(Figure 3E and F). Mice infected with double mutant HG0908
Figure 3. Histopathological examination of mice small intestine inoculated with V. vulnificus strains. Micrographs of ileum of mice
inoculated i.g. with 1610
6 CFU of HG0905 (CMCP6lux; A to D) and isogenic mutants HG0906 (DrtxA1; E), HG0907 (DvvhBA; F), or HG0908
(DrtxA1vvhBA; G). Mice ileum infected with PBS were used for the negative control (H and I). (A) Infiltration of lamina propria in mice ileum infected
with HG0905. Sloughed villi, necrotic debris epithelial cells and leukocyte are abundant in lumen, which are stained by H&E (B), anti-ß-catenin
antibody (brown) (C) and anti-CD45 antibody (brown) (D). Both magnified views of villi infected with HG0906 (E) and HG0907 (F) showed a little
swelling. (G) Intact villi were observed from mice infected with HG0908 (magnification of A, E, F, G and H, 4006; magnification of B, C, D and I, 2006).
doi:10.1371/journal.ppat.1002581.g003
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and H). However, the absence of tissue damage cannot be
conclusively linked to the toxins by this approach because the
bacterial load of wild type in the ileum 8 hours after infection of
10
6 CFU would be much higher than that of single and double
mutant strains due to affects of the loss of cytotoxins on bacterial
growth (Figure 2A and B).
Therefore, we infected mice with increasing CFU so that the
bacterial load in ileum at the point of euthanasia would be
equalized. In mice infected with a CMCP6luxDrtxA1DvvhBA
double mutant (HG0908) at a dose of 5610
7 or 1610
9 CFU
(n=6), there was no tissue damage in the ileum of any of the mice
(Figure 5A) and the epithelial lining appears similar to the PBS
mock infected control group (Figure 3H and I). Notably, even at
the dose high enough to kill 1/6 mice in 8 hour, no tissue damage
occurred. This finding is significant because it indicates that no
other secreted protease or toxin produced by strain CMCP6 is
sufficient to cause visible tissue damage in the absence of
Figure 4. Comparison of HG0905 effect on villi, macrophage and IL-1ß expression to HG0908. (A) Immunohistochemistry staining of
ileum (magnification 4006) for F4/80 antibody (brown) and IL-1ß antibody (brown) in mice infected with 1610
6 CFU of HG0905 (CMCP6lux)o r
various doses of HG0908. (B and C) Fold increase of IL-1ß secretion over PBS control in small intestine from mice infected with (B) 1610
6 CFU of
indicated strain or (C) varying concentrations of HG0905 or HG0908 as indicated were measured by ELISA after 8 hr infection (*, p,0.05; **, p,0.01).
doi:10.1371/journal.ppat.1002581.g004
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PLoS Pathogens | www.plospathogens.org 7 March 2012 | Volume 8 | Issue 3 | e1002581Figure 5. Tissue damage of ileum caused by various doses of single and double mutants. Morphological changes of villi at 8 hr post
infection in one representative mouse and bacterial colonization for all mice inoculated with various doses of HG0908 (CMCP6luxDrtxA1DvvhBA; A),
HG0906 (CMCP6luxDrtxA1; B) and HG0907 (CMCP6luxDvvhBA; C) (magnification 4006). Total recovered CFU from small intestine after removal of
1 cm small intestine for histology are represented as a logarithmic scale, respectively. Values below the dashed line were below the detection limit
(d.l.) and Red6indicates mice that died before 8 hr.
doi:10.1371/journal.ppat.1002581.g005
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lumen exceeded that normally found for wild type by 8 hr post
inoculation.
Staining shows macrophages are present in the lamina propria
at low dose infection of double mutant and are secreting only low
amounts of IL-1b consistent with the low levels of colonization at
8 hours post inoculation (Figure 4A). By contrast, at a high dose,
macrophages are less apparent in the lamina propria and may
have moved to the lumen, where high density staining of IL-1b is
seen (Figure 4). This focusing of a proinflammatory immune
response to the lumen is an effective response since infected mice
are surviving a dose that would kill 100% within 8 hr if infected
with CMCP6lux (HG0905).
MARTXVv and VvhA function additively to cause severe
tissue damage
To determine whether MARTXVv and/or VvhA is directly
responsible for the tissue damage caused by CMCP6lux, similar
increasing dose infections were performed with the single toxin
deletion strains. When 1610
9 CFU of either the isogenic DrtxA1
mutant (n=5) or the DvvhBA mutant (n=5) was inoculated, 40%
or 80% of the mice died within 8 hr post-infection, respectively
(Figure 5B and C). The difference in survival compared to the
double mutant HG0908 shows that the toxins are able to function
independently while the difference between HG0906 and
HG0907 further exemplifies the relative import of MARTXVv
over VvhA for overall survival of CMCP6lux.
At the intermediate infection dose of 5610
7 CFU, the median
number of each single mutant recovered from the small intestines
were 8.1 and 8.2 Log CFU/organ, respectively (Figure 5B and C);
not significantly different from the 7.9 Log CFU/organ recovered
from CMCP6lux (HG0905) inoculated at only 1610
6 CFU. Note
that these median values were calculated from surviving, colonized
mice that were sacrificed for histopathology and do not include
mice that rapidly succumbed to infection or noncolonized mice
with recovered CFU below the detection limit. In the
CMCP6luxDrtxA1 mutant infected mice, only a small portion of
the villi showed necrotic epithelial cells and hypercellularity in the
lamina propria (Figure 5B) indicating, in the absence of
MARTXVv, VvhA induces mild tissue damage accounting for
the modest dissemination of this mutant to the liver (Figure 2C).
By contrast, samples of intestines from mice infected by the
MARTXVv
+ strain DvvhBA mutant showed sloughed villi and an
infiltration of the lamina propria into the lumen indicating
MARTXVv induces tissue damage that is more severe than
associated with VvhA (Figure 5C). This finding is consistent with
the significant ability of this mutant to disseminate to the liver
(Figure 2C). Importantly, we did not observe the severe tissue
destruction similar to that found in the CMCP6lux (HG0905)
infected group in any of these mice suggesting that both cytotoxins
target intestinal epithelial cells and both cause tissue damage that
is additive or possibly even synergistic.
Discussion
Successful and rapid in vivo growth of V. vulnificus is generally
regarded as an essential step in its pathogenesis [11,26]. We
developed a BLI system using the highly virulent V. vulnificus strain
CMCP6 to directly observe how rapid in vivo growth during early
infection can influence the outcome of infection. Wild-type V.
vulnificus CMCP6lux infection expanded quickly in mice very early
after intestinal infection and all the animals progressed to lethality.
By contrast, deletion of one or both of the rtxA1 and vvhA genes led
to bacteria with a in vivo growth delay leading to reduced CFU in
animals by 8–12 hr post infection in the small intestine and other
organs, although there was no in vitro growth defect (Figure 1).
However, while some mice infected with strains missing just one
toxin showed little or no growth, many mice still died from
infection and others that survived infection emitted a high level of
light up to 15 hr (Figure 1A–E). In these mice with detectable
light, the slope of light emission representing the growth rate was
similar to wild type from first detection to peak infection.
Furthermore, co-infection studies revealed the mutant that
produces no cytotoxins has the capacity to grow in vivo, but does
not have the capacity to alter the host environment to promote its
own growth. These findings suggest that the cytolysins cause
another phenomenon beyond simply manipulating bacterial load
in the animal and that this event is important to cause lethal
infection.
Previous studies indicate that dissemination of infection to the
liver is a major predictor of mouse mortality after wound infection
[9], consistent with clinical reports indicating that hepatic
hemorrhage is a frequent cause of death of patients after both
wound and food-borne V. vulnificus infection [27–29]. MARTXVv
and VvhBA from strain CMCP6 are here shown to not only be
associated with enhanced in vivo growth, but also with necrosis of
tissue in the small intestine and translocation of V. vulnificus from
the small intestine to the liver (Figure 2C). Notably, the small
intestine has already been recognized as the site of the most severe
tissue necrosis in human autopsy of V. vulnificus patients [27].
Although both single toxin gene mutants induced from
moderate to severe necrosis and dissemination, the double mutant
was completely restricted to the intestine and no damage was
evident (Figure 3). Close examination of Figure 1A suggests that
light signal from the double mutant occurred predominantly in the
lower abdomen compared to wild type light emission from the
mid-abdomen, an observation consistent with the ability of the
double mutant to grow in vivo during transit through the upper and
lower bowel, accounting for the increased light signal, but the
infection never progressed to the liver.
We next sought to understand if the role of the MARTXVv in
dissemination of CMCP6 during gut infection was to increase the
growth rate within the small intestine during the first few hours to
create a larger pool of bacteria to express VvhA, proteases or other
cytolysins to promote dissemination as proposed by Lo et al. [19]
for wound related infections or, if the role of the toxins is to utilize
the cytolytic activity to directly lyse intestinal epithelial cells to
create a pathway through which the bacteria could disseminate as
proposed by Kim et al. [14]. Our study found that, for strain
CMCP6, both MARTXVv and VvhA function additively to cause
intestinal tissue necrosis. We also found that in vivo growth does
occur in the absence of toxins but is restricted to the intestine,
possibly to the colon as recovered CFU from the small intestine at
12 hr was decreased compared to wild type despite strong light
emission in some animals. Indeed, studies examining wound
infection with strain YJ016 also show less dermal tissue damage
upon deletion of rtxA1, but the effect was negated as secondary to
the effect on decreased bacterial load [19]. Using identical inocula,
we came to the same conclusions. It was only after we used
increased inocula such that bacterial load at the time of euthanasia
was equivalent that the role of toxins on tissue necrosis became
evident. Thus, it is possible that MARTXVv and VvhA will be
shown to also be involved in tissue necrosis during wound
infection, at least for strains CMCP6 and YJ016. However, lethal
dose studies have shown that MARTXVv and VvhA are in general
less important to wound induced lethality than i.g. infection
[12,15,18,19,23], supporting the conclusion by Lo et al. [19] that
alternate factors have a significant role during wound infection.
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epithelium, our results do not negate that the toxins have a
significant role in innate immune defense as well. Both in vitro
and in vivo, V. vulnificus is also known to cause killing of
phagocytic cells [19,21]. In vitro, both toxins are known to induce
NLRP3 dependent caspase-1 activation resulting in necrosis of
macrophages [21]. The absence of phagocytes in hepatic tissue
has been previously noted as a factor that can contribute to
patient mortality [30]. However, our study reveals that V.
vulnificus is inducing massive inflammation, leading to recruit-
ment of monocytes, neutrophils and F4/80-positive macrophag-
es. These results are consistent with an increase of the
proinflammatory cytokines TNF-a, IL-6 and IL-1ß that were
detected in the sera of V. vulnificus septicemic patients [31]. In
our study, the increase of IL-1ß secretion in mice inoculated with
a lower concentration of CMCP6lux suggest that in vivo,t h e
action of toxins against macrophages induces pyroptosis, just as it
does in vitro [21].
A question that remains is whether the toxins are simultaneously
promoting inflammation while attempting to keep it at bay by
killing the recruited cells. A recent study has revealed that some
gut pathogens specifically induce inflammation as a mechanism to
promote rapid growth. Salmonella is known to induce pyroptosis
leading to inflammation [32]. This inflammation then allows
Salmonella to use tetrathionate respiration in the anaerobic
environment of the gut, which promotes bacterial replication
and transmission [33,34]. In the present paper, the tissue damage
of villi in small intestine was clearly apparent (Figure 3 and 5) and
the inflammation as early as 8 hr post infection is severe
(Figure 3D). Thus, while killing of phagocytes is one mechanism
that would promote rapid in vivo growth, particularly in the
bloodstream, it is possible that inflammation itself may promote
growth in the intestine. The ttr genes that encode the tetrathionate
respiration system necessary for Salmonella to grow in response to
inflammation [34] are present in V. vulnificus YJ016 on what
appears to be a pathogenicity island [33,35]. However, the other
sequenced V. vulnificus strains [36], including CMCP6 used in this
study, do not seem to have acquired this island. If the fact that this
pathogen induces the host inflammation to promote their own
outgrowth is a general consequence, our results suggest that a
novel mechanism unrelated, (or in the case of ttr+ YJ016 in
addition to tetrathionate) is required, depending on the strain
isolate.
A final important finding of our work is the evidence that
MARTXVv and VvhBA are directly linked to death of the host.
One mechanism that accounts for the linkage to cell death is that
the cytotoxins promote movement of the bacteria to bloodstream
leading to primary septicemia and septic shock. High bacterial
load in the bloodstream and high serum TNFa concentrations
have been directly linked to death of patients [37,38]. In addition
to septic shock, the toxins might also contribute to multiorgan
failure. This can include necrosis of lung tissue and liver, a
common finding in autopsy patients [28,39]. They could also
cause progression of the infections out of the bloodstream into the
muscle tissue to cause necrotizing fasciitis, another complication of
V. vulnificus infections.
Overall, the present study demonstrates that, for V. vulnificus
isolate CMCP6, MARTXVv, along with VvhBA, performs an
essential role during food-borne V. vulnificus infection after
consumption. These toxins have multiple roles including promo-
tion of rapid in vivo growth, destruction of epithelial tissue, causing
inflammation through induction of pyroptosis, and possibly
causing patient death through tissue destruction in peripheral
organs.
Similar studies performed in other V. vulnificus clinical isolates
will be necessary to determine if findings here with the highly
virulent strain CMCP6 will be broadly applicable to all V. vulnificus
clinical isolates. In particular, we recently found that the
predominance of US clinical isolates from patients with primary
septicemia (represented by strain MO6-24/O) carry a variant of
the MARTXVv toxin that arose by a recombination in the rtxA1
gene with the rtxA gene from Vibrio anguillarum. This recombination
likely accounts for an overall 10-fold reduced virulence of MO6-
24/O in this animal i.g. infection model compared to CMCP6
[15]. Notably, the loss of a domain of unknown function from the
MO6-24/O-type MARTXVv variant did not affect the function of
MARTXVv as a cytolysin in vitro [17] suggesting it would likely
retain the ability to induce necrotic tissue damage during intestinal
infection.
However, it is possible that the reduced potency of the toxin
variant could impact the relative contribution of the toxin to in vivo
growth and tissue damage such that, perhaps, MARTXVv and
VvhA could be found to have a more equal contribution to
intestinal infection by MO6-24/O and similar strains, although we
predict that both toxins would continue to have an additive
contribution to virulence. Alternatively, the kinetics of infection
could be altered such that critical levels of colonization and/or
damage will occur later in the infection cycle.
In addition to MO6-24/O and CMCP6-type MARTXVv
variants, other variants of the toxin have been described that
have undergone more significant changes by horizontal gene
transfer and homologous recombination, including the acquisition
of the ability to covalently crosslink actin in epithelial cells [15,40].
One might predict that these rare variants will have an even more
distinct infection profiles when compared to CMCP6. In any
event, results in this study have established that both MARTXVv
and VvhA contribute to virulence and provide a baseline for
determining if other isolates have similar patterns of disease
progression or whether V. vulnificus infection develops differently
dependent upon the variant of MARTXVv it expresses.
Finally, while it has been shown here that MARTXVv and
VvhA are critical to infection, these are very likely not the only
important virulence factors necessary for intestinal infection. Most
notably, V. vulnificus Biotype 1 can be separated into two distinct
evolutionary lineages: a clinical lineage and environmental lineage
[41]. We have recently shown that bacteria from both lineages
carry genes for both cytolysins [15], even though strains from the
environmental lineage rarely cause clinical infection and are less
virulent in mice [9]. Thus, there must be additional V. vulnificus
factors to define host selection that have yet to be identified and
characterized. These would then work in concert with the
cytotoxins perhaps by improving growth in the human intestine
during infection or by facilitating colonization of the small
intestine by interacting with a human epithelial receptor.
Regardless of the nature of this other virulence gene, the
importance of the cytotoxins cannot be negated since our work
demonstrates that the additive destruction of these toxins is
essential to disease progression.
Materials and Methods
Ethics statement
This study was carried out in strict accordance with the
recommendations in the United States Public Health Service
(USPHS) regulations and applicable federal and local laws. The
protocol (Protocol No. 2009-1016) was approved by the North-
western University Institutional Animal Care and Use Committee
(IACUC) as detailed in methods. All surgery was performed under
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made to minimize suffering.
Bacterial strains and growth conditions
The strains and plasmids used in this study are listed in Table 1.
Escherichia coli strains used for DNA replication or conjugational
transfer of plasmids and Vibrio vulnificus strains were grown in
Luria-Bertani (LB). When appropriate, antibiotics were added to
media at the following concentrations: kanamycin (50 mg/ml),
rifampicin (50 mg/ml) and chloramphenicol (5 mg/ml). Bacterial
growth in LB was monitored using a Beckman DU530
Spectrophotometer.
Generation of V. vulnificus DrtxA1, DvvhBA, DrtxAvvhBA
strains and bioluminescent strains
To inactivate rtxA1, vvhBA and rtxA1vvhBA, overlapping PCR
was applied for the construction of rtxA1 (HG0901), vvhBA
(HG0902) and rtxA1vvhBA (HG0903) deletion mutants [42]
(Table 1). The 9635 bp deleted rtxA1 and the 793 bp deleted
vvhBA open reading frame (ORF) were ligated with SalI-SacI and
XbaI-SacI digested pDS132 [43] forming pHGJ3 and pHGJ4. To
generate the DrtxA1 and DvvhBA mutants by homologous
recombination, E. coli SM10lpir and S17lpir (containing pHGJ3
and pHGJ4) were used as a conjugal donor to V. vulnificus CMCP6
with spontaneous rifampicin resistance. The DrtxA1vvhBA double
mutant was also generated through conjugation of pHGJ3 to
HG0902 (Table 1). The conjugation and isolation of the
transconjugants were conducted using sucrose counter selection
previously described [42].
A pCM17 containing luxCDABE and hok/sok plasmid [24] was
used for generation of bioluminescent V. vulnificus strains. To
create the conjugatable plasmid, 251 bp of oriT DNA from
pGP704 was inserted into NheI-SalI digested pCM17 to create
pHGJ1. pHGJ1 was then digested with HindIII followed by
religation to inactivate the luciferase genes and create pHGJ2
(Table 1). CMCP6lux (HG0905) and isogenic rtxA1 (HG0906),
vvhBA (HG0907) and rtxA1vvhBA (HG0908) mutants were
generated by conjugal transfer of pHGJ1 and HG0909 and
HG0910 were generated by conjugal transfer of pHGJ2 (Table 1).
Mouse infection and imaging of bioluminescence from
mice
The roles of the V. vulnificus CMCP6 MARTXVv and VvhA in
pathogenesis were examined using a mouse model. Female
C57BL/6 mice (5–6 weeks old, Harlan, Indianapolis, IN) were
individually anesthetized with an i.p. injection of 100 ml of PBS
solution containing 10 mg/ml ketamine and 2 mg/ml xylazine per
mouse, i.g. inoculated with 50 mlo f1 610
6 CFU of the indicated
V. vulnificus strains. Images were acquired using an IVIS 100
(Xenogen Corporation, Alameda, CA). During image acquisition,
mice were anesthetized using ketamine-xylazine cocktail at each
image cycle. All images were acquired at a preset exposure of
20 sec with medium binning and f/stop=1 so images could be
compared over time. Photons per second emitted by each mouse
were quantified and analyzed by defining regions of interest (ROI),
using the Living Image 1.0 software. Severely moribund mice
unlikely to survive to the next imaging cycle were euthanized after
imaging and counted as non-survivors.
Table 1. Bacterial strains and plasmids used in this study.
Strain or plasmid Relevant characteristics
a Sources or references
Bacterial Strains
V. vulnificus
CMCP6 Clinical isolate; virulent, Rif
r P. Gulig
HG0901 CMCP6 with DrtxA1,R i f
r [15]
HG0902 CMCP6 with DvvhBA,R i f
r This study
HG0903 CMCP6 with DrtxA1DvvhBA,R i f
r This study
HG0905 CMCP6 with pHGJ1, Rif
r,K m
r This study
HG0906 HG0901 with pHGJ1, Rif
r,K m
r This study
HG0907 HG0902 with pHGJ1, Rif
r,K m
r This study
HG0908 HG0903 with pHGJ1, Rif
r,K m
r This study
HG0909 CMCP6 with pHGJ2, Rif
r,K m
r This study
HG0910 HG0903 with pHGJ2, Rif
r,K m
r This study
E. coli
SM10 lpir thi thr leu tonA lacY supE recA::RP4-2-Tc::Mu l pir;K m
r; host for p-requiring plasmids; conjugal donor [46]
S17 lpir thi pro hsdR
2 hsdM
+ recA::RP4-2-Tc::Mu l pir;S m
r; host for p-requiring plasmids; conjugal donor [47]
Plasmids
pCM17 bioluminescent vector; Km
r [24]
pDS132 Suicide vector; oriR6K; Cm
r [43]
pHGJ1 pCM17 with oriT; bioluminescent vector; Km
r This study
pHGJ2 pHGJ1 with DluxCDABE;K m
r This study
pHGJ3 DrtxA1 fragment in pDS132; Cm
r This study
pHGJ4 DvvhBA fragment in pDS132; Cm
r This study
a,C m
r, chloramphenicol resistant; Km
r, kanamycin resistant; Rif
r, rifampicin resistant.
doi:10.1371/journal.ppat.1002581.t001
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To observe the tissue damage in mice small intestine, infected
mice were sacrificed at specific time points and 1 cm of ileum
immediately adjacent to the cecal-ileal junction was fixed by 10%
neutral phosphate buffered formaldehyde solution (Sigma, St. Louis,
MO) for 16 hr. Histopathology was performed at the Northwestern
University Pathology Core Facility. The ileum was embedded in
paraffin, and stained with hematoxylin and eosin (H&E).
A single immunohistochemical staining procedure was per-
formed to characterize the necrotized cells and to detect the
cytokines secretion. Briefly, tissue sections were placed in a 60uC
oven overnight for tissue to adhere. The sections were dewaxed in
xylene, rehydrated through graded alcohols to water. Antigen
retrieval was done by placing the slides in citrate buffer and pressure
cooked up to 125uC for 30 sec and gradually reduced to 90uC over
40 min. Slides were then cooled down at room temperature for
20 min and placed in DAKO butter (DAKO, Carpineteria, CA).
Then immunostaining for ß–catenin, CD45, F4/80, and IL-1ß was
performed on a DAKO Autostainer Plus using a DAKO Envision
system (DAKO). Sections were first quenched with hydrogen
peroxide (H2O2) for 10 min and incubated with primary antibodies
for 60 min. Primary rabbit polyclonal antibodies to ß-catenin,
CD45 and IL-1ß (Abcam, Cambridge, UK), at 1:50 dilution, and
rat monoclonal antibodies to F4/80 (Abcam), at a 1:100 dilution,
were used. Secondary antibodies were applied at a dilution of 1:200
for 30 min, followed by incubation with polymer link streptavidin-
horseradish peroxidase (HRP) reagent and 3,39-diaminobenzidine
(DAB; DAKO). The slides were counter-stained with blue Mayer’s
Hematoxylin and primary antibodies were omitted in negative
controls. Then the stained slides were photographed using a Zeiss
Axioskop (MicroImaging, Thornwood, NY) microscope with
Nuance spectral camera (CRI, Woburn, Mass).
Determination of bacterial colonization in mice organs
and ELISA for mice cytokine in small intestine
Mouse colonization assays were performed essentially as
described earlier for Vibrio cholerae infection [44]. Briefly, five
C57BL/6 female mice (5–6 weeks old, Harlan, Indianapolis, IN)
per each group were euthanized by cervical dislocation under
anesthesia at 8 or 12 hr after inoculation of the indicated V.
vulnificus strains or PBS. After terminal ileum dissection for
histology, the liver, spleen and remaining small intestine were
dissected. Then it was homogenized in 5 ml (small intestine and
liver) or 3 ml (spleen) of PBS and serially diluted for plate counts of
recovered colony forming units (CFU) on LB plate containing
rifampicin. Mice for which fewer than 10 colonies were recovered
from 50 ml of the homogenated extract were plotted below the
detection limit line. Recovery of bacteria is reported as a
Colonization Index (Col. Ind.) calculated as CFUrecovered/
CFUinoculated or CFU/organ at logarithmic scale. The remaining
homogenates of small intestine was centrifuged at 134006g for
5 min at 4uC and the supernatant were kept at 280uC. The
supernatants were thawed on ice immediately prior to assay. IL-1ß
levels in small intestines were determined from homogenated
extracts by ELISA (Enzyme-linked immunosorbent assay, BioLe-
gend, San Diego, CA) kits according to manufacturer’s instruction.
Virulence determination and cytotoxicity assay of lux+ V.
vulnificus strains
Virulence of lux+ V. vulnificus strains was determined in a
morbidity assay as previously described [15] and the LD50 for each
strain was calculated by the method of Reed and Muench [45].
To examine the cytotoxicity of lux+ V. vulnificus strains, the
HeLa cells were grown in Dulbecco’s modified Eagle’s medium
containing 10% fetal bovine serum and seeded in 12 well culture
plates to a density of 8.5610
5 cells per well. After growing
overnight at 37uCi n5 %C O 2, the monolayer of HeLa cells were
infected with lux+ V. vulnificus strains at a multiplicity of infection of
25 and the cytotoxicity was then determined by measuring the
activity of LDH in the supernatant at 1 to 5 hr post-infection using
a CytoTox 96 Non-Radioactive Cytotoxicity Assay Kit (Promega,
Madison, WI) according to manufacturer’s instructions.
Statistical analysis
All data were graphed and analyzed using GraphPad Prism 4 for
MacIntoshSoftware(SanDiego,CA).StatisticalsignificanceforLDH
assays, growth curve, and ELISA assays was determined in pairwise
comparisons using a student t-test. A Mann-Whitney non-parametric
t-test comparing means was used for mouse colonization studies.
Significance of survival curves was determined using the log-rank test.
Supporting Information
Figure S1 The effect of luciferase-expressing V. vulni-
ficus in survival proportions of mice and in vitro growth
kinetics. (A) 5–6 weeks old C57BL/6 mice were infected with
CMCP6, HG0905 (CMCP6lux) and HG0909 (lux- CMCP6)
strains i.g. and survival proportions of mice were compared. (B)
Cultures of CMCP6 and HG0905 were grown in LB broth at
30uC (*, p,0.05; **, p,0.01).
(TIF)
Figure S2 Effect of MARTXVv and VvhA in lux+ V.
vulnificus on HeLa cell lysis activity. HeLa cells were
infected with the HG0905, HG0906, HG0907 and HG0908 at
MOI of 25 and LDH activity were determined at various
incubation times (*, p,0.05; **, p,0.01).
(TIF)
Table S1 Lethality of luciferase-expressing V.vulnificus
strains to mice.
(DOCX)
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